Intrinsiqq
Hypha Labs Inc. logo

Hypha Labs Inc. Financials

FUNI

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 16 available years
Income Statement
TTM
SEP 2025
~1.3:1 split
SEP 2024
SEP 2023
SEP 2022
SEP 2021
Revenues
Revenue$3–––$3$3
Cost of Revenue$2–––$2$2
Gross Profit$1–––$1$1
General & Administrative$0$1$1$0$0$1
Provision for Doubtful Accounts$0–––$0-$0
Total Operating Expenses$1$3$2$0$1$1
Operating Income-$1-$3-$2-$0-$1-$1
Non-Operating
Net Interest Expense-$0-$0-$0-$0-$0-$0
Other Non-Operating Income (Expense)-$1$0$1$0-$1$0
EBT (Earnings Before Tax)–-$3-$1-$1––
Income Tax Expense––$0–––
Earnings from Continuing Ops–-$3-$1-$1-$2–
Net Income
Net Income-$2-$3-$1$0-$2-$1
Per Share Data
Revenue Per Share$0.03–––$0.04$0.04
EPS (Basic)-$0.03-$0.02-$0.01$0.00-$0.03-$0.01
EPS (Diluted)-$0.03-$0.02-$0.01$0.00-$0.03-$0.01
Weighted Avg Shares (Basic)82.2M135.1M101.3M83.9M74.2M65.9M
Weighted Avg Shares (Diluted)82.2M135.1M101.3M83.9M74.2M65.9M
Shares Outstanding82.2M135.1M101.3M83.9M74.2M65.9M

Hypha Labs (FUNI) financials: revenue, profit and margins

Hypha Labs (FUNI) generated about n/a in revenue and -$2 million in net income over the trailing twelve months, growing at roughly 7.3% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Hypha Labs profitable?+

Hypha Labs reported about -$2 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How fast is Hypha Labs growing?+

Hypha Labs's revenue has compounded at roughly 7.3% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside FUNI's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 14 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 14 Oct 2026. How this is calculated.

Fiscal year ends Sep.

Peers

Services-Testing Laboratories · Pick stocks to compare with FUNI

CompareIntrinsic value
AIDX20/20 Biolabs, Inc.
$0.16-12.72%36
ABSIAbsci Corporation
$7.51-7.97%10
ONMDOnemednet Corp.
$4.70+4.21%30
ISPCIspecimen Inc.
$0.45-14.58%10
BIAFBioAffinity Technologies Inc.
$1.65-10.81%20
FOXOFoxo Technologies Inc.
$0.10+0.00%53
ELVGElvictor Group Inc.
$6.30+0.00%52
GXXMDGex Management, Inc.
$0.00-25.00%39

Spot a number that looks wrong? Check it in FUNI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing FUNI

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.